Even though the FDA has not approved daptomycin for the treatment of infection with vancomycin-resistant enterococci, clinicians often use it off-label in patients with severe enterococcal ...

The addition of vancomycin to beta-lactam prophylaxis in ... The pharmaceutical company from which the investigational trial product was purchased removed the commercial labels and placed a ...

Study: Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures ...

Vancomycin flushing syndrome, previously known as "red man syndrome," can occur during or after a dose of vancomycin, an antibiotic for treating some severe infections. Learn more.

Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures.

Vancomycin always has been a problematic agent for treating patients with Staphylococcus infections because of its poor tissue penetration and slow bactericidal activity. In recent years, its use ...

Vancomycin is the drug of choice for treating cellulitis, study suggests Date: October 28, 2010 Source: Henry Ford Health System Summary: Patients admitted to the hospital for the common bacterial ...

Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin’s clinical durability. PLOS Pathogens , 2024; 20 (8): e1012422 DOI ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...